Trima Accel® 81001
Trima Accel 81001 is an apheresis system (FDA Class II; FDA product code GKT, Separator, automated, blood cell, diagnostic) made by Terumo BCT, Inc., listed under FDA premarket submission BK970023 and listed in FDA GUDID since 15 Sep 2016 (UDI-DI 05020583810013), active as of 8 Nov 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
510(k) BK970023
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05020583810013 | Date15 Sep 2016 | StatusListed |
| United States | FDA 510(k) | NumberBK970023 | Date— | StatusActive |
Official records
- AccessGUDID record 05020583810013
From the FDA record
- Device description
- Automated Blood Collection System
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA premarket submission BK970023 Active
- FDA GUDID UDI-DI 05020583810013 listed 15 Sep 2016 Listed
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Trima Accel®
- Generic name
- Apheresis system
- Model / reference
- 81001
- Primary DI / UDI-DI
- 05020583810013
- FDA product code
- GKT
- GMDN term
- Apheresis system
- Device class
- Class II
- Regulation number
- 864.9245
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Apheresis system.